- Report
- November 2024
- 159 Pages
Global
From €2201EUR$2,500USD£1,902GBP
- Report
- May 2024
- 176 Pages
Global
From €2201EUR$2,500USD£1,902GBP
- Report
- August 2022
- 96 Pages
Global
From €4397EUR$4,995USD£3,801GBP
- Report
- July 2021
- 151 Pages
Europe
From €3037EUR$3,450USD£2,625GBP
- Report
- September 2023
- 270 Pages
Global
€4221EUR$4,795USD£3,648GBP
- Report
- March 2026
- 90 Pages
Indonesia
From €2509EUR$2,850USD£2,169GBP
- Report
- February 2026
- 90 Pages
Japan
From €2509EUR$2,850USD£2,169GBP
- Report
- February 2025
- 148 Pages
Global
From €3477EUR$3,950USD£3,005GBP
- Report
- April 2024
- 134 Pages
Global
From €3477EUR$3,950USD£3,005GBP
- Report
- December 2024
- 120 Pages
Global
From €3477EUR$3,950USD£3,005GBP
- Report
- January 2024
- 140 Pages
Global
From €3742EUR$4,250USD£3,234GBP
- Report
- September 2023
- 143 Pages
Global
From €3918EUR$4,450USD£3,386GBP
- Report
- September 2022
- 248 Pages
Global
From €3169EUR$3,600USD£2,739GBP
- Report
- May 2022
- 91 Pages
North America
From €1321EUR$1,500USD£1,141GBP
- Report
- January 2025
- 220 Pages
Global
From €4397EUR$4,995USD£3,801GBP
- Report
- January 2024
- 249 Pages
Global
€4397EUR$4,995USD£3,801GBP
- Report
- November 2023
- 170 Pages
Global
From €3918EUR$4,450USD£3,386GBP
- Report
- January 2023
- 170 Pages
Global
From €3918EUR$4,450USD£3,386GBP
- Report
- December 2022
- 206 Pages
Africa, Middle East, Turkey Africa, Middle East, Turkey
From €3037EUR$3,450USD£2,625GBP
- Report
- December 2022
- 117 Pages
From €3037EUR$3,450USD£2,625GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more